Universidad del País Vasco/Euskal Herriko Unibertsitatea-ko ikertzaileekin lankidetzan egindako argitalpenak (17)

2021

  1. What Can We Do with the Data of Deceased People? A Normative Proposal

    European Review of Private Law, Vol. 29, Núm. 5, pp. 785-806

2020

  1. An EU Comparative Analysis of the Regulation of Clinical Trials Supervisory Bodies in the Aftermath of Regulation 536/2014

    European Public Law, Vol. 26, Núm. 2, pp. 307-330

  2. Machine learning as a proposal for a better application of food nanotechnology regulation in the European Union

    Current Topics in Medicinal Chemistry, Vol. 20, Núm. 4, pp. 324-332

2019

  1. Complex networks and machine learning: From molecular to social sciences

    Applied Sciences (Switzerland)

2018

  1. Chapter 12 Gene Editing in Human Embryos. A Comment on the Ethical Issues Involved

    Philosophy and Medicine (Springer Science and Business Media B.V.), pp. 173-187

  2. New experimental and computational tools for drug discovery: Medicinal chemistry, personalized medicine, ethical & legal issues - Part-V

    Current Topics in Medicinal Chemistry

  3. Personalized medicine and medicinal chemistry: Toward a legal framework in the European Union

    Current Topics in Medicinal Chemistry, Vol. 18, Núm. 25, pp. 2165-2173

  4. Perturbation theory machine learning models: Theory, regulatory issues, and applications to organic synthesis, medicinal chemistry, protein research, and technology

    Current Topics in Medicinal Chemistry, Vol. 18, Núm. 14, pp. 1203-1213

2017

  1. CRISPR-Cas in medicinal chemistry: Applications and regulatory concerns

    Current Topics in Medicinal Chemistry, Vol. 17, Núm. 30, pp. 3308-3315

  2. New experimental and computational tools for drug discovery: From chemistry to biology. part-III

    Current Topics in Medicinal Chemistry

2015

  1. MI-NODES multiscale models of metabolic reactions, brain connectome, ecological, epidemic, world trade, and legal-social networks

    Current Bioinformatics, Vol. 10, Núm. 5, pp. 692-713

  2. MIANN models of networks of biochemical reactions, ecosystems, and U.S. supreme court with Balaban-Markov indices

    Current Bioinformatics, Vol. 10, Núm. 5, pp. 658-671

2014

  1. ANN multiscale model of Anti-HIV drugs activity vs AIDS prevalence in the US at county level based on information indices of molecular graphs and social networks

    Journal of Chemical Information and Modeling, Vol. 54, Núm. 3, pp. 744-755

  2. Modeling complex metabolic reactions, ecological systems, and financial and legal networks with MIANN models based on Markov-Wiener node descriptors

    Journal of Chemical Information and Modeling, Vol. 54, Núm. 1, pp. 16-29

2013

  1. Markov-Randić indices for QSPR re-evaluation of metabolic, parasite-host, fasciolosis spreading, brain cortex and legal-social complex networks

    Current Bioinformatics, Vol. 8, Núm. 4, pp. 401-415

  2. S2SNET: A tool for transforming characters and numeric sequences into star network topological indices in chemoinformatics, bioinformatics, biomedical, and social-legal sciences

    Current Bioinformatics, Vol. 8, Núm. 4, pp. 429-437

2011

  1. Markov Entropy Centrality: Chemical, Biological, Crime, and Legislative Networks

    TOWARDS AN INFORMATION THEORY OF COMPLEX NETWORKS: STATISTICAL METHODS AND APPLICATIONS (BIRKHAUSER BOSTON), pp. 199-258